Featured Research

from universities, journals, and other organizations

Math models enhance current therapies for coronary heart disease

Date:
December 9, 2013
Source:
Society for Industrial and Applied Mathematics
Summary:
Coronary heart disease accounts for 18 percent of deaths in the United States every year. The disease results from a blockage of one or more arteries that supply blood to the heart muscle due to an inflammatory condition called artherosclerosis, leading to progressive buildup of fatty plaque near the surface of the arterial wall. A paper published proposes a mathematical model to improve currently-employed treatments of coronary heart disease.

Illustration of a cross-section of a coronary artery with plaque buildup. The coronary artery is located on the surface of the heart. ‘A’ shows the deflated balloon catheter inserted into the narrowed coronary artery. The balloon is inflated in ‘B’—this compresses the plaque and restores the size of the artery. C shows the widened artery.
Credit: National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services

Coronary heart disease accounts for 18% of deaths in the United States every year. The disease results from a blockage of one or more arteries that supply blood to the heart muscle. This occurs as a result of a complex inflammatory condition called artherosclerosis, which leads to progressive buildup of fatty plaque near the surface of the arterial wall.

Related Articles


In a paper published last month in the SIAM Journal on Applied Mathematics, authors Sean McGinty, Sean McKee, Roger Wadsworth, and Christopher McCormick devise a mathematical model to improve currently-employed treatments of coronary heart disease (CHD).

"CHD remains the leading global cause of death, and mathematical modeling has a crucial role to play in the development of practical and effective treatments for this disease," says lead author Sean McGinty. "The use of mathematics allows often highly complex biological processes and treatment responses to be simplified and written in terms of equations which describe the key parameters of the system. The solution of these equations invariably provides invaluable insight and understanding that will be crucial to the development of better treatments for patients in the future."

The accumulation of plaque during CHD can result in chest pain, and ultimately, rupture of the artherosclerotic plaque, which causes blood clots blocking the artery and leading to heart attacks. A common method of treatment involves inserting a small metallic cage called a stent into the occluded artery to maintain blood flow.

However, upon insertion of a stent, the endothelium -- the thin layer of cells that lines the inner surface of the artery -- can be severely damaged. The inflammatory response triggered as a result of this damage leads to excessive proliferation and migration of smooth muscle cells (cells in the arterial wall that are involved in physiology and pathology) leading to re-blocking of the artery. This is an important limitation in the use of stents. One way to combat this has been the use of stents that release drugs to inhibit the smooth muscle cell proliferation, which causes the occlusion. However, these drug-eluting stents have been associated with incomplete healing of the artery. Studies are now being conducted to improve their performance.

"Historically, stent manufacturers have predominantly used empirical methods to design their drug-eluting stents. Those stents which show promising results in laboratory and clinical trials are retained and those that do not are discarded," explains McGinty. "However, a natural question to ask is, what is the optimal design of a drug-eluting stent?"

The design of drug-eluting stents is severely limited by lack of understanding of the factors governing their drug release and distribution. "How much drug should be coated on the stent? What type of drug should be used?" McGinty questions. "All of these issues, of course, are inter-related. By developing models of drug release and the subsequent uptake into arterial tissue for current drug-eluting stents, and comparing the model solution with experimental results, we can begin to answer these questions."

The model proposed by the authors considers a stent coated with a thin layer of polymer containing a drug, which is embedded in the arterial wall, and a porous region of smooth muscle cells embedded in an extracellular matrix.

When the polymer region and the tissue region are considered as a coupled system, it can be shown under certain conditions that the drug release concentration satisfies a special kind of integral equation called the Volterra integral equation, which can be solved numerically. The drug concentration in the system is determined from the solution of this integral equation. This gives the mass of drug within cells, which is of primary interest to clinicians.

The simple one-dimensional model proposed in the paper provides analytical solutions to this complex problem. "While the simplified one and two-dimensional models that our group and others have recently developed have provided qualitative results and useful insights into this problem, ultimately three-dimensional models which capture the full complex geometry of the stent and the arterial wall may be required," McGinty says. In a complex environment with pulsating blood flow, wound healing, cell proliferation and migration, and drug uptake and binding, the process of drug release from the stent may involve a multitude of factors, which could be best understood by three-dimensional models. "This is especially relevant when we want to consider the drug distribution in diseased arteries and when assessing the performance of the latest stents within complex geometries, where for instance, the diseased artery may bifurcate," says McGinty. "We are therefore currently investigating the potential benefits of moving to three-dimensional models."


Story Source:

The above story is based on materials provided by Society for Industrial and Applied Mathematics. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sean McGinty, Sean McKee, Roger M. Wadsworth, Christopher McCormick. Modeling Arterial Wall Drug Concentrations Following the Insertion of a Drug-Eluting Stent. SIAM Journal on Applied Mathematics, 2013; 73 (6): 2004 DOI: 10.1137/12089065X

Cite This Page:

Society for Industrial and Applied Mathematics. "Math models enhance current therapies for coronary heart disease." ScienceDaily. ScienceDaily, 9 December 2013. <www.sciencedaily.com/releases/2013/12/131209124547.htm>.
Society for Industrial and Applied Mathematics. (2013, December 9). Math models enhance current therapies for coronary heart disease. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2013/12/131209124547.htm
Society for Industrial and Applied Mathematics. "Math models enhance current therapies for coronary heart disease." ScienceDaily. www.sciencedaily.com/releases/2013/12/131209124547.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins